[ Return to Index ]

Saliva Diagnostic receives favorable ruling in patent infringement litigation with Chembio Diagnostic Systems

Saliva Diagnostic Systems, Inc. (Framingham, MA) , a manufacturer and marketer of rapid tests for infectious diseases, received a favorable ruling in connection with litigation brought against it by Chembio Diagnostic Systems, Inc.

On September 27, 2005 the Hon. Joanna Seybert, issued her Claim Construction Ruling on the interpretation of the patent claims in the suit. The Court ruled that SDS' broader interpretation of SDS' patent claims was correct, and rejected Chembio's arguments seeking to narrow coverage afforded by SDS' '864 patent. Chembio originally brought the suit seeking a ruling that its Sure Check device does not infringe SDS' patent, as well as other relief. SDS has countersued for patent infringement.

With the broad scope of the '864 patent now established, SDS will seek an expedited Court schedule for remaining proceedings to recover damages and to enjoin Chembio from selling or offering for sale the Chembio Sure Check device. SDS considers this a major victory in the matter.

Saliva Diagnostic manufactures and markets a patented rapid point of care testing device for infectious diseases, as well as oral fluid specimen collection devices using a patented volume adequacy indicator for drugs of abuse testing and other clinical uses. These products are sold in the United States as well as internationally to various distributors for use in clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations.

Saliva Diagnostic Systems, Inc.
+1-508-872-2625
www.salv.com